India recorded 86,961 cases of the coronavirus disease (Covid-19), the lowest in six days, and 1,130 deaths between Sunday and Monday morning, according to the Union Ministry of Health on Monday. The country’s tally rose to 5,487,580 and the death toll to 87,882, data showed at 8 a.m. M.
There are 1,003,299 active cases of the coronavirus disease and 4,396,399 recoveries after 93,356 patients were cured and discharged nationwide in the last 24 hours. This brings India’s recovery rate to 80.11%.
The Health Ministry has said that India, the second most affected country, has the highest number of recovered Covid-19 patients globally, constituting 19% of total recoveries worldwide. “India ranks first in the world in terms of total recoveries. More than 43 lakh have been recovered. Recoveries from India make up 19% of total global recoveries, ”the ministry said.
Union Health Minister Harsh Vardhan said on Sunday that the Indian Council for Medical Research (ICMR) is actively exploring saliva-based testing for the detection of Covid-19 and stated that there is no significant or drastic mutation in the Strains of Sars-CoV-2, which causes coronavirus disease, have been found in India so far.
Vardhan said during an interaction with his social media followers that ICMR has been conducting large-scale sequencing of nationally representative strains of the Sars-CoV-2 virus collected over several months at different times. He added that detailed results on the mutations and evolution of the virus will be available in early October.
Read also | Taj Mahal reopens to visitors with strict Covid-19 protocol: everything you need to know
ICMR has successfully completed the second round of the serological survey, to know the prevalence of coronavirus disease in the country, and the final phase of results is currently being analyzed. “The analysis of the final phase of the survey is already underway and will offer a comparison with the results of the first survey,” it said in a statement.
The serosurvey is performed by testing blood samples from selected individuals for antibodies to Sars-CoV-2, the virus that causes Covid-19. Determine a past infection, considering that most patients have no symptoms and not all are tested for viral infection.
The Health Minister, during their interaction, also sought to allay fears caused by the suspension of trials of the Oxford-AstraZeneca candidate vaccine, saying that vaccine development is a complex process and that trials have only been restarted. after a committee of independent research experts allowed them to continue.
He explained the difference between various vaccines under clinical trial in India and that since the formulations, dosages and routes of administration are different for vaccines, their mechanisms of action are also different.
Vardhan also spoke about the role of traditional medicine in the current context, saying that the AYUSH ministry has developed research protocols to validate the claims of various Ayush practitioners for Covid-19 solutions, although no formulation has been validated as a drug. specific.
Globally, more than 959,332 people have died, according to the Johns Hopkins University coronavirus tracker.
.